سعر دورموفارين 0.03/3 مجم 21 قرص 2026

Combined oral contraceptive: ethinylestradiol 0.03 mg + drospirenone 3 mg, 21 tablets, CID.

• Prevention of pregnancy (combined oral contraceptive).Population: Females of reproductive potentialDailyMed / FDA

• High risk of arterial/venous thrombotic disease; current/history of breast cancer or other estrogen/progestin-sensitive cancer; hepatic tumors/disease; undiagnosed abnormal uterine bleeding; pregnancy; concomitant ombitasvir/paritaprevir/ritonavir-containing regimens (see US label full list).International label, same formulation · DailyMed / FDA

• Boxed warning (US CHCs): cigarette smoking increases serious CV events risk especially >35 y. VTE risk; hyperkalemia risk with drospirenone (antimineralocorticoid) especially with other K+-sparing drugs; blood pressure; carbohydrate/lipid effects; headache/migraine; liver disease.International label, same formulation · DailyMed / FDA

• CYP3A4 inducers / certain HCV regimens / potassium-sparing drugsMajorEnzyme inducers reduce contraceptive efficacy; some HCV combinations contraindicated; K+-sparing agents increase hyperkalemia risk with drospirenone.DailyMed / FDA

• Contraindicated in pregnancy; discontinue if pregnancy occurs. CHCs are not for use during pregnancy.International label, same formulation · DailyMed / FDA
• CHCs may reduce milk production; advise alternative contraception when breastfeeding if possible (see US label).International label, same formulation · DailyMed / FDA

• Ethinylestradiol: As part of an estrogen-progestogen combination: inhibits ovulation by suppressing the mid-cycle LH surge, thickens cervical mucus and makes the endometrium unreceptive to implantation.
• Drospirenone: Binds progesterone receptors; antimineralocorticoid and antiandrogenic activity.